Imunohistochemical detection myocardial necrosis in stillbirth and neonatal death

Pediatric and Developmental Pathology

Volumn 3, Issue 1, 2000, Pages 40-47

  Lazda, E J ^a   Batchelor, W H ^a   Cox, P M ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

Complement 9; Fetus; Immunohistochemistry; Infant; Myocardial infarction

Indexed keywords

COMPLEMENT COMPONENT C9; BIOLOGICAL MARKER; MONOCLONAL ANTIBODY;

ARTICLE; DIAGNOSTIC VALUE; HEART INFARCTION; HEART MUSCLE NECROSIS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; NEWBORN; NEWBORN DEATH; PREVALENCE; PRIORITY JOURNAL; STILLBIRTH; FEMALE; FETUS DEATH; GESTATIONAL AGE; HEART MUSCLE; IMMUNOLOGY; MALE; NECROSIS; PATHOLOGY; PREGNANCY;

ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; COMPLEMENT C9; FEMALE; FETAL DEATH; GESTATIONAL AGE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MYOCARDIUM; NECROSIS; PREGNANCY;

EID: 85047676344     PISSN: 10935266     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100240050005     Document Type: Article

References (41)

1. de Sa DJ, Donnelly WH. Myocardial necrosis in the newborn. Perspect Pediatr Pathol 1984;8:295-311.
2. de Sa DJ. Myocardial changes in immature infants requiring prolonged ventilation. Arch Dis Child 1977;52:138-147.
3. de Sa DJ. Coronary arterial lesions and myocardial necrosis in stillbirths and infants. Arch Dis Child 1979;54:918-930.
4. Donnelly WH, Bucciarelli RL, Nelson RM. Ischemic papillary muscle necrosis in stressed newborn infants. J Pediatr 1980;96:295-300.
5. Setzer E, Ermocilla R, Tonkin I, John E, Sansa M, Cassady G. Papillary muscle necrosis in a neonatal autopsy population: incidence and associated clinical manifestations. J Pediatr 1980;96:289-294.
6. Donnelly WH. Ischemic myocardial injury: the histopathologic spectrum in 167 cases. Lab Invest 1982;46:5P.
7. Schafer H, Mathey D, Hugo F, Bhakdi S. Deposition of the terminal C5b-9 complement complex in infarcted areas of human myocardium. J Immunol 1986;137:1945-1949.
8. Edston E, Kawa K. Immunohistochemical detection of early myocardial infarction. An evaluation of antibodies against the terminal complement complex (C5b-9). Int J Legal Med 1995;108:27-30.
9. Doran JP, Howie AJ, Townend JN, Bonser RS. Detection of myocardial infarction by immunohistological staining for C9 on formalin fixed, paraffin wax embedded sections. J Clin Pathol 1996;49:34-37.
10. Adinolfi M. Human complement: onset and site of synthesis during fetal life. Am J Dis Child 1977;131:1015-1023.
11. Adinolfi M, Beck SE. Human complement C7 and C9 in fetal and newborn sera. Arch Dis Child 1975;50:562-564.
12. Lassiter HA, Watson SW, Seifring ML, Tanner JE. Complement factor 9 deficiency in serum of human neonates. J Infect Dis 1992;166:53-57.
13. Adamkin D, Stitzel A, Urmson J, Farnett ML, Post E, Spitzer R. Activity of the alternative pathway of complement in the newborn infant. J Pediatr 1978;93:604-608.
14. Genest DR, Williams MA, Greene MF. Estimating the time of death in stillborn fetuses: I. Histologic evaluation of fetal organs; an autopsy study of 150 stillborns. Obstet Gynecol 1992;80:575-584.
15. Hammond EH, Yowell RL, Nunoda S, et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 1989;8:430-443.
16. Foerster A. Vascular rejection in cardiac transplantation. A morphological study of 25 human cardiac allografts. APMIS 1992;100:367-376.
17. Bidani AK, Roberts JL, Schwartz MM, Lewis EJ. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 1980;69:849-858.
18. Ziporen L, Goldberg I, Arad M, et al. Libman-Sacks endocarditis in the antiphospholipid syndrome: immunopathologic findings in deformed heart valves. Lupus 1996; 5:196-205.
19. Butman S, Espinoza LR, Del Carpio J, Osterland CK. Rheumatoid pericarditis. Rapid deterioration with evidence of local vasculitis. JAMA 1977;238:2394-2396.
20. Hatle L, Melbye OJ. Immunoglobulins and complement in chronic myocardial disease. A myocardial biopsy study. Acta Med Scand 1976;200:385-389.
21. Maisch B, Buschel G, Izumi T, et al. Four years of experience in endomyocardial biopsy - an immunohistologic approach. Heart Vessels (Suppl) 1985;1:59-67.
22. Dawson L, Talwar KK, Chopra P. Significance of pathological parameters of endomyocardial biopsy in clinical outcome of patients of dilated cardiomyopathy - II. Value of cardiac immune complexes and heart reactive antibodies. Indian Heart J 1991;43:421-425.
23. Maisch B. Immunologic regulator and effector mechanisms in myocarditis and perimyocarditis. Heart Vessels (Suppl) 1985;1:209-217.
24. Dragatakis LN, Klassen J, Huttner I, Fraser DG, Poirier NL, Klassen GA. Autoimmune myocarditis: a clinical entity. Can Med Assoc J 1979;120:317-321.
25. Maisch B, Bauer E, Cirsi M, Kochsiek K. Cytolytic cross-reactive antibodies directed against the cardiac membrane and viral proteins in coxsackievirus B3 and B4 myocarditis. Characterization and pathogenetic relevance. Circulation 1993;87 (Suppl IV):IV19-IV65.
26. Molina HA, Milei J, Storino R. Chronic Chagas' myocardiopathy. Demonstration of in vivo bound immunoglobulins in heart structures by the immunoperoxidase technique. Cardiology 1984;71:297-306.
27. Goldstein I, Scebat L, Renais J, Hadjinsky P, Dutartre J. Rheumatic-like carditis induced in rabbits by cross-reacting antigens: Streptococcus A polysaccharide and rabbit aortic glycoproteins. Isr J Med Sci 1983;19:483-490.
28. Poltera AA, Hochmann A, Lambert PH. A model for cardiopathy induced by Trypanosoma brucei brucei in mice. A histologic and immunopathologic study. Am J Pathol 1980;99:325-351.
29. Rosenberg HS, Donnelly WH. The cardiovascular system. In: Wigglesworth JS, Singer DB, eds. Textbook of Fetal and Perinatal Pathology, 2nd ed. Boston: Blackwell Scientific Publications, 1998;652-654.
30. Lodge-Patch I. The ageing of cardiac infarcts and its influence on cardiac rupture. Br Heart J 1951;6:115.
31. Ramkissoon RA. Macroscopic identification of early myocardial infarction by dehydrogenase alterations. J Clin Pathol 1966;19:479.
32. Bouchardy B, Majno G. Histopathology of early myocardial infarcts. A new approach. Am J Pathol 1974;74:301-330.
33. Young NA, Mondestin MA, Bowman RL. Ischemic changes in fetal myocardium. An autopsy series. Arch Path Lab Med 1994;118:289-292.
34. Derias NW, Adams CW. The non-specific nature of the myocardial wavy fibre. Histopatholy 1979;3:241-245.
35. Humphrey SM, Vanderwee MA. Factors affecting the development of contraction band necrosis during reperfusion of the isolated isovolumic rat heart. J Mol Cell Cardiol 1986;18:319-329.
36. Vakeva A, Morgan BP, Tikkanen I, Helin K, Laurila P, Meri S. Time course of complement activation and inhibitor expression after ischemic injury of rat myocardium. Am J Pathol 1994;144:1357-1368.
37. Mathey D, Schofer J, Schafer HJ, et al. Early accumulation of the terminal complement-complex in the ischaemic myocardium after reperfusion. Eur Heart J 1994;15:418-423.
38. Davies MJ, Mann J, eds. The pathology of ischaemic heart disease. In: Davies MJ, Mann J, eds. Systemic Pathology, Vol 10B, Acquired Diseases of the Heart. New York: Churchill Livingstone, 1995;43-47.
39. Baroldi G. Diseases of the coronary arteries. In: Silver MD, ed. Cardiovascular Pathology, Vol. 1. New York: Churchill Livingstone, 1983;406-408.
40. Karch SB, Billingham ME. Myocardial contraction bands revisited. Hum Pathol 1986;17:9-13.
41. Thomsen H, Held H. Susceptibility of C5b-9(m) to postmortem changes. Int J Legal Med 1994;106:291-293.